Equities Research Analysts’ updated eps estimates for Thursday, November 23rd:

BHP Billiton plc (LON:BLT) had its overweight rating reissued by analysts at Morgan Stanley. The firm currently has a GBX 1,500 ($19.73) target price on the stock.

Deere & (NYSE:DE) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating.

Intesa Sanpaolo S.p.A. (BIT:ISP) had its buy rating reiterated by analysts at UBS Group AG.

ITV plc (LON:ITV) had its overweight rating reissued by analysts at Morgan Stanley. The firm currently has a GBX 230 ($3.03) price target on the stock.

SouFun Holdings Limited (NYSE:SFUN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $5.25 target price on the stock. According to Zacks, “Fang Holdings Limited operates as a real estate Internet portal primarily in China. It provides marketing, e-commerce, listing and other value-added services for real estate and home furnishing and improvement sectors. Fang Holdings Limited, formerly known as SouFun Holdings Limited, is based in Beijing, China. “

Sappi (OTCMKTS:SPPJY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $8.00 price target on the stock. According to Zacks, “SAPPI LTD -ADR is the world ‘s leading producer of coated fine paper. They hold major market shares in Europe, North America and Africa. They have customers in over 100 countries worldwide. Their manufacturing operations span eight countries on three continents. “

Seritage Growth Properties (NYSE:SRG) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Seritage Growth Properties is a self-administered, self-managed REIT primarily engaged in the real property business through its operating partnership, Seritage Growth Properties, L.P. Seritage Growth Properties is based in HOFFMAN ESTATES, United States. “

Sasol (NYSE:SSL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Sasol Limited is engaged in the mining and processing of coal. It also produces chemicals, explores for and refines crude oil, and manufactures fertilizers and explosives. In addition, it converts coal to petrochemicals products, such as diesel fuels and gasoline. “

Staffing 360 Solutions (NASDAQ:STAF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Staffing 360 Solutions, Inc. is engaged in a global buy-and-build strategy through the acquisition of staffing organizations in the US and the UK. Through both organic growth and acquisitions, the Company provides permanent placement services in the finance and accounting, administrative, engineering and IT staffing space. Staffing 360 Solutions, Inc. is headquartered in New York, with its UK headquarters in London. “

Grupo Supervielle (NYSE:SUPV) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Grupo Supervielle SA is a private domestically-owned financial group primarily in Argentina. The Company owns Banco Supervielle S.A., an Argentine private domestically-owned bank which operates primary in the City of Buenos Aires and the Greater Buenos Aires metropolitan area, Mendoza and San Luis. Grupo Supervielle SA is based in Bueno Aires, Argentina. “

Mast Therapeutics (NASDAQ:SVRA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States. “

Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $12.00 price target on the stock. According to Zacks, “Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s lead program, SIRPaFc (TTI-621), is a fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory (do not eat) signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic (eat) signals. A Phase 1 clinical trial (NCT02663518) evaluating SIRPaFc is ongoing. Trillium also has a proprietary medicinal chemistry platform, using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties. “

USA Technologies (NASDAQ:USAT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “USA Technologies is a leader in the networking of distributed assets, wireless non-cash transactions, associated financial/network services and energy management. USA Technologies provides networked credit card and other non-cash systems in the vending, commercial laundry, hospitality and digital imaging industries. USA Technologies is an IBM Business Partner. The Company has marketing agreements with Cingular Wireless, Honeywell, MEI, Unilever and ZiLOG Corporation. “

Verso Corporation (NYSE:VRS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Verso Corporation is engaged in the paper industry. The Company produces coated freesheet, coated ground wood and uncoated super calendered papers and pulp. It serves to magazine and catalog publishers, commercial printers, specialty retail merchandisers and paper merchants. The company operates primarily in Kentucky, Maine, Maryland, Michigan, Minnesota and Wisconsin. Verso Corporation is based in Memphis, United States. “

William Hil Adr (OTCMKTS:WIMHY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $16.00 price target on the stock. According to Zacks, “William Hill PLC provides sports betting and gaming services. It offers licensed betting offices, telephone based-betting operations and online betting, offers odds and takes bets on an assortment of sporting and other events. The company operates primarily in the United Kingdom, Australia, the United States, Italy and Spain. William Hill PLC is headquartered in London, the United Kingdom. “

Align Research began coverage on shares of Zinc Media Group PLC (LON:ZIN). Align Research issued a conviction-buy rating and a GBX 1.32 ($0.02) price target on the stock.

Receive News & Ratings for BHP Billiton plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BHP Billiton plc and related companies with MarketBeat.com's FREE daily email newsletter.